ZONOVATE

Product Overview

About ZONOVATE

ZONOVATE is a medication containing the active ingredient TUROCTOCOG ALFA, used to treat bleeding disorders, particularly hemophilia A. It is a recombinant form of the human coagulation factor VIII, essential for blood clotting.

Key Benefits & Uses

• Treatment of bleeding episodes in patients with hemophilia A
• Prevention of bleeding in patients undergoing surgery or other invasive procedures
• Replacement therapy for patients with hemophilia A who have developed antibodies against factor VIII

Active Ingredient & Action

TUROCTOCOG ALFA works by replacing the deficient or missing factor VIII in the blood, facilitating proper blood clotting and preventing excessive bleeding. It is administered intravenously and has a rapid onset of action, providing effective control of bleeding episodes.

Important Notes

It is essential to follow the recommended dosage and administration schedule for ZONOVATE, as provided by your healthcare professional. Regular monitoring of factor VIII levels and bleeding episodes is necessary to ensure optimal treatment outcomes. Inform your doctor about any allergies, medical conditions, or medications you are taking before starting treatment with ZONOVATE.